Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen <i>et al</i>.

Poppelaars, Pomme B M; van Tuyl, Lilian H D; Boers, Maarten

Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al.

Poppelaars, Pomme B M; van Tuyl, Lilian H D; Boers, Maarten.

Affiliation

Poppelaars PBM; Rheumatology, Amsterdam Rheumatology and Immunology Centre - VU University Medical Centre, Amsterdam, The Netherlands.
van Tuyl LHD; Rheumatology, Amsterdam Rheumatology and Immunology Centre - VU University Medical Centre, Amsterdam, The Netherlands.
Boers M; Rheumatology, Amsterdam Rheumatology and Immunology Centre - VU University Medical Centre, Amsterdam, The Netherlands maartenguard-ard@yahoo.com.

Ann Rheum Dis ; 79(10): e125, 2020 10.

Article in En | MEDLINE | ID: mdl-31285259

Subject(s)

Arthritis, Rheumatoid; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid/drug therapy; Cohort Studies; Follow-Up Studies; Humans

Key words

disease activity; early rheumatoid arthritis; treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2020 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google